Sfoglia per AUTORE
LINHARTOVA J
Collezione AOU San Luigi di Orbassano
Items : 1
In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutants. in BMC cancer / BMC Cancer. 2016 Aug 2;16:572. doi: 10.1186/s12885-016-2635-0.
2016
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Soverini S; De Benedittis C; Castagnetti F; Gugliotta G; Mancini M; Bavaro L; Machova Polakova K; Linhartova J; Iurlo A; Russo D; Pane F; Saglio G; Rosti G; Cavo M; Baccarani M; Martinelli G;